Go Pro
OTCMKTS:CNTTF

CannTrust (CNTTF) Stock Price, News & Analysis

CannTrust logo

About CannTrust Stock (OTCMKTS:CNTTF)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.43 million shs
Average Volume
528,025 shs
Market Capitalization
$1.01 billion
P/E Ratio
137.18
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CannTrust Holdings Inc is a Canadian licensed producer of medical and recreational cannabis products. The company cultivates, processes and distributes a range of offerings, including dried flower, oils, pre-rolls and vape cartridges, under the CannTrust brand. Through a vertically integrated model, CannTrust oversees cultivation, manufacturing, quality assurance and distribution to serve patient and adult-use markets across Canada.

The company’s cultivation infrastructure comprises both greenhouse and indoor facilities in Pelham and Vaughan, Ontario, where controlled environment agriculture techniques are applied to optimize cannabinoid and terpene profiles. CannTrust holds a Good Manufacturing Practices (GMP) certification from European regulators, enabling it to export medical cannabis for research and clinical trial purposes in Europe. Its Canadian distribution network reaches provincial cannabis authorities and licensed private retailers.

Founded in 2014, CannTrust expanded rapidly alongside Canada’s legalization of adult-use cannabis, securing multiple federal production and sales licenses. In 2019, the company faced regulatory compliance issues that led to a suspension of certain cultivation authorizations and a subsequent leadership restructuring. Following a period of corporate reorganization and asset divestitures in the early 2020s, CannTrust refocused on its core cultivation and product development operations, emphasizing regulatory compliance and renewal of its market position within the evolving cannabis industry.

AI Generated. May Contain Errors.

Receive CNTTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CannTrust and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNTTF Stock News Headlines

CannTrust Holdings Inc CNTTQ
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel
Annexon (NASDAQ: ANNX)
Nektar Therapeutics (NASDAQ: NKTR)
OptiNose (NASDAQ: OPTN)
Cybin (NYSEMKT: CYBN)
See More Headlines

CNTTF Stock Analysis - Frequently Asked Questions

Shares of CNTTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:CNTTF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
137.18
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$15.96 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
105,608,000
Free Float
N/A
Market Cap
$1.01 billion
Optionable
Not Optionable
Beta
4.52
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (OTCMKTS:CNTTF) was last updated on 8/25/2026 by MarketBeat.com Staff.
From Our Partners